DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Richardson P, Schlossman R, Munshi N. et al.
A phase 1 trial of lenalidomide (REVLIMID®) with bortezomib (VELCADE®) in relapsed and refractory multiple myeloma.
Blood 2005; 106: 110a-
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.